NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/12/2025
Back to search
Official data from USPTO
BAG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
06/13/2025
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 40
Filing date
11/12/2021
Registration date
01/02/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/02/2024
Last transaction
06/13/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
HARMON, RAYMOND
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BAG Holding GmbH
BAG Health Care GmbH
Representatives
Andrew D. Dorisio Dickinson Wright PLLC
Technical classification
Nice Classes
Class 1Class 5Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industryscience and photographyas well as in agriculturehorticulture and forestry except fungicidesherbicidesinsecticidesparasiticides; chemical preparations for preserving foodstuffs; enzymes for scientific and research use; primers being DNA primers for scientific and research use; nucleotides for scientific and diagnostic research use; assays for scientific research purposesenzyme immuno assays for detecting relevant microorganismstoxinsgenetically modified organisms (GMO)allergens in foodstuffs; indicators for controlling of sterilisation and disinfectionchemical indicators for monitoring sterilization processes other than for medical or veterinary purposes
Class 5
Pharmaceutical and veterinary preparations for infusion and injectiondantrolene sodium for injectioninsulinbotulinum toxin for medical use for use in the treatment of excessive sweating; sanitary preparations for medical purposes; medicated serums for infusion and injectiondantrolene sodium for injectioninsulinbotulinum toxin for medical use for use in the treatment of excessive sweating; enzymes for medical purposes; primers being DNA primers for diagnostic and medical usenot for scientific or research use; nucleotides for medical usenot for scientific or research use; diagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditionsimmunofluorescence tests for detecting antibodies; diagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditionshaemaglutination tests for detecting antibodies; diagnostic kits for use in disease testingtest kits consisting primarily of reagents and anti-serums for identifying human proteins; specimen collection kits for use in virus testing comprised primarily of swabs for medical purposesquick tests for detecting viruses or identifying proteins; all afore-mentioned for medical purposes
Class 40
Treatment of materials in the nature of aseptic filling of containers with chemical solutions and suspensions for others; treatment of materialslyophilisation in the nature of freeze drying of parenterals for others
Publications
History of USPTO decisions and trademark events.
40 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/22/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/03/2024
FIMP
FINAL DISPOSITION PROCESSED
04/02/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/02/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/17/2023
PUBO
PUBLISHED FOR OPPOSITION
10/17/2023
GPNX
NOTIFICATION PROCESSED BY IB
10/16/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/27/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/11/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
09/11/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/11/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
09/11/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/08/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/08/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/25/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/05/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/05/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/06/2023
GNFR
FINAL REFUSAL E-MAILED
04/06/2023
CNFR
FINAL REFUSAL WRITTEN
04/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/06/2023
RFNT
REFUSAL PROCESSED BY IB
11/14/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/21/2022
RFRR
REFUSAL PROCESSED BY MPU
10/21/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/30/2022
CNRT
NON-FINAL ACTION WRITTEN
08/29/2022
DOCK
ASSIGNED TO EXAMINER
08/24/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
04/22/2022
MAFR
APPLICATION FILING RECEIPT MAILED
02/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/04/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/03/2022
Continuous trademark protection
Get notified about every new filing that threatens BAG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.